Striatal spine plasticity in Parkinson's disease

scientific article

Striatal spine plasticity in Parkinson's disease is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.3389/FNANA.2010.00133
P932PMC publication ID3004242
P698PubMed publication ID21179580
P5875ResearchGate publication ID49703560

P2093author name stringYoland Smith
Rosa M Villalba
P2860cites workThe familial Parkinsonism gene LRRK2 regulates neurite process morphologyQ24317613
Morphological changes in dendritic spines associated with long-term synaptic plasticityQ29614372
The functional anatomy of basal ganglia disordersQ29617461
Primate models of movement disorders of basal ganglia originQ29618489
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neuronsQ29619181
Evidence of a breakdown of corticostriatal connections in Parkinson's disease.Q33214147
The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neuronesQ33256442
Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure.Q33319566
Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesisQ33595218
A neurocomputational method for fully automated 3D dendritic spine detection and segmentation of medium-sized spiny neuronsQ33729745
Dendritic spine formation and pruning: common cellular mechanisms?Q33826755
Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbensQ33904968
Lrrk2 localization in the primate basal ganglia and thalamus: a light and electron microscopic analysis in monkeysQ34005501
Pathophysiology of the basal ganglia in Parkinson's disease.Q34070859
Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine lossQ34116613
Ca(2+) signaling in dendritic spinesQ34278072
Genesis of dendritic spines: insights from ultrastructural and imaging studiesQ34288088
The thalamostriatal system: a highly specific network of the basal ganglia circuitryQ34550491
Cocaine regulates MEF2 to control synaptic and behavioral plasticityQ34818266
Inversion of dopamine responses in striatal medium spiny neurons and involuntary movementsQ35932567
Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson diseaseQ35991189
Calcium regulation of actin dynamics in dendritic spines.Q36093658
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease.Q36145938
Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neuronsQ36169973
Perforated postsynaptic densities: probable intermediates in synapse turnoverQ36312956
Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonismQ36763909
Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats.Q36946633
Balancing structure and function at hippocampal dendritic spinesQ37088448
Dendritic spine plasticity--current understanding from in vivo studies.Q37114209
The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian statesQ37130756
Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeysQ37186952
Altered dendritic spine plasticity in cocaine-withdrawn ratsQ37233538
Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brainsQ37264478
Quantal analysis and synaptic anatomy — integrating two views of hippocampal plasticityQ40486104
Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic functionQ40766021
MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons.Q40817289
Reversal of experimental parkinsonism by lesions of the subthalamic nucleusQ41241320
Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion.Q42468515
Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats.Q42493069
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.Q44102387
Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonismQ46670738
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.Q46896175
Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkeyQ48117953
Calbindin D-28k as a marker for the associative cortical territory of the striatum in macaqueQ48191029
Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway.Q48454428
Sesquicentenary of the birthday of Santiago Ramón y Cajal, the father of modern neuroscienceQ48508765
A Golgi study of rat neostriatal neurons: Light microscopic analysisQ48932428
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson diseaseQ49069694
The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method.Q51120870
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders?Q58064430
Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with ageQ69262673
Calcium in the spine apparatus of dendritic spines in the dentate molecular layerQ72697493
GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervationQ73491179
Alterations in rat striatal glutamate synapses following a lesion of the cortico- and/or nigrostriatal pathwayQ74240596
Anatomy and physiology of the basal ganglia: relevance to Parkinson's disease and related disordersQ82029272
P921main subjectParkinson's diseaseQ11085
striatumQ1319792
P304page(s)133
P577publication date2010-12-10
P1433published inFrontiers in NeuroanatomyQ1893158
P1476titleStriatal spine plasticity in Parkinson's disease
P478volume4

Reverse relations

cites work (P2860)
Q46449896-NMDA R/+VDR pharmacological phenotype as a novel therapeutic target in relieving motor-cognitive impairments in Parkinsonism
Q27330366Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function
Q41050952Basal Ganglia Circuits: What's Now and Next?
Q28271277Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects
Q35799129Cortical Composition Hierarchy Driven by Spine Proportion Economical Maximization or Wire Volume Minimization
Q36775249Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?
Q28591970Deficient Wnt signalling triggers striatal synaptic degeneration and impaired motor behaviour in adult mice
Q37185190Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine?
Q36256517Dopamine D1 Receptor-Mediated Transmission Maintains Information Flow Through the Cortico-Striato-Entopeduncular Direct Pathway to Release Movements
Q38722989Dysregulation of striatal projection neurons in Parkinson's disease
Q34200166Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat
Q37213655Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease.
Q47786283Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons.
Q38766091Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity?
Q48377970Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease
Q26781619Morphological changes of glutamatergic synapses in animal models of Parkinson's disease
Q35176103Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease
Q30389213On the Complexity of Brain Disorders: A Symptom-Based Approach
Q49825935Peripheral Administration of Tetanus Toxin Hc Fragment Prevents MPP+ Toxicity In Vivo
Q36379339Recent advances in applying mass spectrometry and systems biology to determine brain dynamics.
Q28648007Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia
Q31105385Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression
Q91750012Structural plasticity of GABAergic and glutamatergic networks in the motor thalamus of parkinsonian monkeys
Q26864858The BAI subfamily of adhesion GPCRs: synaptic regulation and beyond
Q38922002The cellular basis of dendrite pathology in neurodegenerative diseases
Q35146020The corticostriatal and corticosubthalamic pathways: two entries, one target. So what?
Q36951038The role of exercise in facilitating basal ganglia function in Parkinson's disease
Q26996624The thalamostriatal system in normal and diseased states
Q34390400Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
Q42505593Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.
Q90671795What and How Can Physical Activity Prevention Function on Parkinson's Disease?

Search more.